ARCHIVED: NOT AVAILABLE FOR CREDIT
Bacterial Identification by Mass Spectrometry
Mass spectrometry (MS) is a mature analytic technology in the research community that has only recently begun to make significant inroads into the clinical laboratory. Matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a relatively recent addition to the MS arsenal and shows great promise for the clinical laboratory.
Originally presented June 29, 2011 and Re-recorded November 28, 2012 in Salt Lake City, Utah.
Mark Fisher, PhD, D(ABMM)
Medical Director, Bacteriology, Antimicrobials, Parasitology, and Infectious Disease Rapid Testing Laboratories, ARUP Laboratories
Assistant Professor of Pathology, University of Utah School of Medicine
Dr. Fisher is the medical director of the Bacteriology, Antimicrobials, Parasitology, and Infectious Disease Rapid Testing laboratories at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. Dr. Fisher obtained a PhD in microbiology and molecular genetics from Emory University and a master of science in microbiology from Idaho State University. He subsequently completed fellowships in microbial pathogenesis at the Rocky Mountain Laboratories (NIH) and in medical microbiology at the University of Utah. He is board certified in medical microbiology, and his research interests include microbial pathogenesis and transmission of vector borne pathogens.
After this presentation, participants will be able to:
- Understand relevant principles of mass spectrometry.
- List advantages and disadvantages of available platforms.
- Describe the uses of mass spectrometry in the clinical microbiology laboratory.
University of Utah School of Medicine and ARUP Laboratories